期刊论文详细信息
Lipids in Health and Disease
A clustering analysis of lipoprotein diameters in the metabolic syndrome
Donna K Arnett6  Jose M Ordovas5  Paul N Hopkins1  Michael Y Tsai8  Hemant K Tiwari2  Ingrid B Borecki4  Edmond K Kabagambe6  W Timothy Garvey3  Stephen Glasser7  Alexis C Frazier-Wood2 
[1] Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA;Department of Biostatistics, Section on Statistical Genetics, University of Alabama at Birmingham, School of Public Health, AL, USA;Birmingham VA Medical Center, Birmingham, AL, USA;Division of Statistical Genomics, Department of Genetics, Washington University, School of Medicine, 4444 Forest Park Boulevard-Box 8506, St. Louis, MO, USA;JM-USDA-HNRCA, Tufts University, Boston, MA, USA;Nutrition Obesity Research Center, University of Alabama at Birmingham, School of Public Health, AL, USA;Department of Medicine, Division of Preventive Medicine, University of Alabama at Birmingham, AL, USA;Department of Laboratory Medicine and Pathology, University of Minnesota, MN
关键词: fasting glucose;    hypertriglyceridemia;    hypertension;    waist circumference;    GOLDN;    latent class analysis;    Metabolic Syndrome;    nuclear resonance spectroscopy;    insulin resistance;    lipoprotein particle diameter;   
Others  :  1212356
DOI  :  10.1186/1476-511X-10-237
 received in 2011-10-28, accepted in 2011-12-19,  发布年份 2011
PDF
【 摘 要 】

Background

The presence of smaller low-density lipoproteins (LDL) has been associated with atherosclerosis risk, and the insulin resistance (IR) underlying the metabolic syndrome (MetS). In addition, some research has supported the association of very low-, low- and high-density lipoprotein (VLDL HDL) particle diameters with components of the metabolic syndrome (MetS), although this has been the focus of less research. We aimed to explore the relationship of VLDL, LDL and HDL diameters to MetS and its features, and by clustering individuals by their diameters of VLDL, LDL and HDL particles, to capture information across all three fractions of lipoprotein into a unified phenotype.

Methods

We used nuclear magnetic resonance spectroscopy measurements on fasting plasma samples from a general population sample of 1,036 adults (mean ± SD, 48.8 ± 16.2 y of age). Using latent class analysis, the sample was grouped by the diameter of their fasting lipoproteins, and mixed effects models tested whether the distribution of MetS components varied across the groups.

Results

Eight discrete groups were identified. Two groups (N = 251) were enriched with individuals meeting criteria for the MetS, and were characterized by the smallest LDL/HDL diameters. One of those two groups, one was additionally distinguished by large VLDL, and had significantly higher blood pressure, fasting glucose, triglycerides, and waist circumference (WC; P < .001). However, large VLDL, in the absence of small LDL and HDL particles, did not associate with MetS features. These associations held after additionally controlling for VLDL, LDL and HDL particle concentrations.

Conclusions

While small LDL diameters remain associated with IR and the MetS, the occurrence of these in conjunction with a shift to overall larger VLDL diameter may identify those with the highest fasting glucose, TG and WC within the MetS. If replicated, the association of this phenotype with more severe IR-features indicated that it may contribute to identifying of those most at risk for incident type II diabetes and cardiometabolic disease.

【 授权许可】

   
2011 Frazier-Wood et al; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150614092500803.pdf 279KB PDF download
Figure 1. 18KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Circulation 2009, 120:1640-5.
  • [2]Arad Y, Newstein D, Cadet F, Roth M, Guerci AD: Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arteriosclerosis, Thrombosis, and Vascular 2001, 21:2051-8.
  • [3]Wood AC, Glasser S, Garvey WT, Kabagambe EK, Borecki IB, Tiwari HK, Tsai MY, Hopkins PN, Ordovas JM, Arnett DK: Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the Metabolic Syndrome. Lipids in Health and Disease 10(1):143.
  • [4]Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y: Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003, 52:453-62.
  • [5]Mykkanen L, Haffner SM, Rainwater DL, Karhapaa P, Miettinen H, Laakso M: Relationship of LDL size to insulin sensitivity in normoglycemic men. Arteriosclerosis, Thrombosis, and Vascular Biology 1997, 17:1447-53.
  • [6]Hulthe J, Bokemark L, Wikstrand J, Fagerberg B: The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arteriosclerosis, Thrombosis, and Vascular Biology 2000, 20:2140-7.
  • [7]Kathiresan S, Otvos JD, Sullivan LM, Keyes MJ, Schaefer EJ, Wilson PWF, D'Agostino RB, Vasan RS, Robins SJ: Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 2006, 113(1):20-9.
  • [8]Gray RS, Robbins DC, Wang W, Yeh JL, Fabsitz RR, Cowan LD, Welty TK, Lee ET, Krauss RM, Howard BV: Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology 1997, 17:2713-20.
  • [9]Barakat HA, Carpenter JW, McLendon VD, Khazanie P, Leggett N, Heath J, Marks R: Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. Diabetes 1990, 39:1527-33.
  • [10]Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Despres JP: Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000, 102:179-84.
  • [11]Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G: Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002, 25:971-6.
  • [12]Goff DC Jr, D'Agostino RB Jr, Haffner SM, Otvos JD: Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 2005, 54:264-70.
  • [13]Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins AJ, Klein RL, Garvey WT: Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 2004, 27:978-83.
  • [14]Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, Wagenknecht LE, Haffner SM: Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study. Circulation 111:3465-72.
  • [15]Kabagambe EK, Ordovas JM, Tsai MY, Borecki IB, Hopkins PN, Glasser SP, et al.: Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis 2009, 203:633-9.
  • [16]Lai CQ, Arnett DK, Corella D, Straka RJ, Tsai MY, Peacock JM, Adiconis X, Parnell LD, Hixson JE, Province MA, Ordovas JM: Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:1417-25.
  • [17]Jeyarajah EJ, Cromwell WC, Otvos JD: Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clinics in laboratory medicine 2006, 26(4):847-70.
  • [18]Jones BL, Nagin Roeder KDS: A SAS procedure based on mixture models for estimating developmental trajectories. Sociological Methods & Research 2010, 29:374-93.
  • [19]Andruff H, Carraro N, Thompson A, Gaudreau P: Latent Class Growth Modelling: A Tutorial. Tutorials in Quantitative Methods for Psychology 2009, 5(1):11-24.
  文献评价指标  
  下载次数:14次 浏览次数:14次